title: Letter to the Editor: Managing Dabigatran-Related Bleeding.
authors.affiliation: Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Jerrold H
authors.initials: JH
authors.lastname: Levy
authors.affiliation: McMaster University, Hamilton, Ontario, Canada.
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Weitz
authors.affiliation: Northwestern University, Chicago, Illinois, USA.
authors.forename: Richard A
authors.initials: RA
authors.lastname: Bernstein
authors.affiliation: McMaster University, Hamilton, Ontario, Canada.
authors.forename: John
authors.initials: J
authors.lastname: Eikelboom
authors.affiliation: Boston University School of Medicine, Boston, Massachusetts, USA.
authors.forename: Elaine
authors.initials: E
authors.lastname: Hylek
authors.affiliation: Leiden University Medical Center, Leiden, Netherlands.
authors.forename: Menno V
authors.initials: MV
authors.lastname: Huisman
authors.affiliation: Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Reilly
authors.affiliation: University of Heidelberg, Heidelberg, Germany.
authors.forename: Thorsten
authors.initials: T
authors.lastname: Steiner
authors.affiliation: University Medical Center, Groningen, Netherlands.
authors.forename: Pieter
authors.initials: P
authors.lastname: Kamphuisen
authors.affiliation: Tuen Mun Hospital, Tuen Mun, NT, Hong Kong.
authors.forename: Chak-Wah
authors.initials: CW
authors.lastname: Kam
authors.affiliation: Pennsylvania Hospital, University of Pennsylvania, Philadelphia, Pennsylvania, USA cvpollack@gmail.com.
authors.forename: Charles V
authors.initials: CV
authors.lastname: Pollack
mesh_terms: D000925:Anticoagulants; D001281:Atrial Fibrillation; D000069604:Dabigatran; D006470:Hemorrhage; D006801:Humans
chemical_list: D000925:Anticoagulants; D000069604:Dabigatran